It will take more than hype and hope to realize the therapeutic and economic benefits offered by personalized medicine based on the application of genetics
Intermittent androgen deprivation therapy (ADT) may be just as effective as continuous ADT in men with PSA recurrence after radical therapy for prostate cancer, according to a new Canadian study.